Oct. 24 at 4:04 PM
$NVEC up 9.7% in a month — what's driving the optimism? 🚀
Despite a 6% drop in Q2 revenue, a 21% rise in non-defense product sales is boosting investor confidence. Management's focus on medical devices and robotics markets is seen as a strategic pivot away from weaker defense contracts.
Discover the full story here 👉 https://www.zacks.com/stock/news/2776696/nve-corp-reports-yy-declines-in-profit-revenues-in-q2?cid=sm-stocktwits-2-2776696-body-17563&ADID=SYND_STOCKTWITS_TWEET_2_2776696_BODY_17563